GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (OTCPK:BETRF) » Definitions » Current Deferred Revenue

BETRF (BetterLife Pharma) Current Deferred Revenue : $0.00 Mil (As of Jul. 2024)


View and export this data going back to 2010. Start your Free Trial

What is BetterLife Pharma Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

BetterLife Pharma's current deferred revenue for the quarter that ended in Jul. 2024 was $0.00 Mil.

BetterLife Pharma Current Deferred Revenue Historical Data

The historical data trend for BetterLife Pharma's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Current Deferred Revenue Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BetterLife Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BetterLife Pharma Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (OTCPK:BETRF) » Definitions » Current Deferred Revenue
Comparable Companies
TSXV:XRTX XCNQ:TRYP XCNQ:CHGX TSXV:HEM XCNQ:DRUG TSXV:RKV TSXV:RP TSX:APLI XCNQ:MESC XCNQ:GLOW OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
NPAU:Germany BETR:Canada
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
Website
https://www.abetterlifepharma.com
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.
Executives
Barbara-jean Anne Bormann-kennedy director, officer: President 1188 BROADWAY, SUITE 306, SOMERVILLE MA 02144
Moira Ong officer: Chief Financial Officer 2392 LAWSON AVENUE, WEST VANCOUVER A1 V7V 2E6
Hassan Salari director, 10 percent owner 1517 WEST 58TH AVENUE, VANCOUVER A1 V6P 1W6
Ahmad Doroudian director, officer: Chairman 1275 WEST 6TH AVENUE, VANCOUVER A1 V6H 1A6